References
- Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000;287:1442-6. https://doi.org/10.1126/science.287.5457.1442
- Fink DW Jr. FDA regulation of stem cell-based products. Science 2009;324:1662-3. https://doi.org/10.1126/science.1173712
- Moos M Jr. Stem-cell-derived products: an FDA update. Trends Pharmacol Sci 2008;29:591-3. https://doi.org/10.1016/j.tips.2008.09.003
- Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003;108:2212-8. https://doi.org/10.1161/01.CIR.0000095788.78169.AF
- Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrowderived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21. https://doi.org/10.1056/NEJMoa060186
- Huikuri HV, Kervinen K, Niemela M, et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 2008;29:2723-32. https://doi.org/10.1093/eurheartj/ehn436
- Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-209. https://doi.org/10.1056/NEJMoa055706
- Tendera M, Wojakowski W, Ruzyllo W, et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009;30:1313-21. https://doi.org/10.1093/eurheartj/ehp073
- Traverse JH, Henry TD, Ellis SG, et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 2011;306:2110-9. https://doi.org/10.1001/jama.2011.1670
- Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011;378:1847-57. https://doi.org/10.1016/S0140-6736(11)61590-0
- Ang KL, Chin D, Leyva F, et al. Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med 2008;5:663-70. https://doi.org/10.1038/ncpcardio1321
- Perin EC, Willerson JT, Pepine CJ, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 2012;307:1717-26. https://doi.org/10.1001/jama.2012.418
- Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005;102:11474-9. https://doi.org/10.1073/pnas.0504388102
- Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010;107:913-22. https://doi.org/10.1161/CIRCRESAHA.110.222703
- Ishikawa K, Ladage D, Takewa Y, et al. Development of a preclinical model of ischemic cardiomyopathy in swine. Am J Physiol Heart Circ Physiol 2011;301:H530-7. https://doi.org/10.1152/ajpheart.01103.2010
- Mewton N, Rapacchi S, Augeul L, et al. Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model. Basic Res Cardiol 2011;106:1247-57. https://doi.org/10.1007/s00395-011-0214-8
- Schuleri KH, Boyle AJ, Centola M, et al. The adult Gottingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies. Comp Med 2008;58:568-79.
- Zhang J, Wilke N, Wang Y, et al. Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31 P-MRS study. Circulation 1996;94:1089-100. https://doi.org/10.1161/01.CIR.94.5.1089
- Verdouw PD, van den Doel MA, de Zeeuw S, Duncker DJ. Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc Res 1998;39:121-35. https://doi.org/10.1016/S0008-6363(98)00069-8
- Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72. https://doi.org/10.1161/01.CIR.81.4.1161
- McCall FC, Telukuntla KS, Karantalis V, et al. Myocardial infarction and intramyocardial injection models in swine. Nat Protoc 2012;7:1479-96. https://doi.org/10.1038/nprot.2012.075
- Zhang H, Wang H, Li N, Duan CE, Yang YJ. Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research. Heart Fail Rev 2013. [Epub ahead of print]
- Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-201. https://doi.org/10.1038/nm912
- Sil AK, Maeda S, Sano Y, Roop DR, Karin M. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 2004;428:660-4. https://doi.org/10.1038/nature02421
- Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC. Novel injectable bioartificial tissue facilitates targeted, less invasive, largescale tissue restoration on the beating heart after myocardial injury. Circulation 2005;112(9 Suppl):I173-7.
- Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7. https://doi.org/10.1126/science.284.5411.143
- Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005;102:11474-9. https://doi.org/10.1073/pnas.0504388102
- Hou D, Youssef EA, Brinton TJ, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005;112(9 Suppl):I150-6.
- Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006;27:1114-22.
- Strauer BE, Brehm M, Zeus T, et al. [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. Dtsch Med Wochenschr 2001;126:932-8. https://doi.org/10.1055/s-2001-16579-1
- Dib N, Menasche P, Bartunek JJ, et al. Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv 2010;3:265-75. https://doi.org/10.1016/j.jcin.2009.12.013
- Patel AN, Geffner L, Vina RF, et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005;130:1631-8. https://doi.org/10.1016/j.jtcvs.2005.07.056
- Pompilio G, Steinhoff G, Liebold A, et al. Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results. Thorac Cardiovasc Surg 2008;56:71-6. https://doi.org/10.1055/s-2007-989351
- Zhao Q, Sun Y, Xia L, Chen A, Wang Z. Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg 2008;86:1833-40. https://doi.org/10.1016/j.athoracsur.2008.08.068
- Dib N, Michler RE, Pagani FD, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005;112:1748-55. https://doi.org/10.1161/CIRCULATIONAHA.105.547810
- Losordo DW, Schatz RA, White CJ, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007;115:3165-72. https://doi.org/10.1161/CIRCULATIONAHA.106.687376
- Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001;37:1726-32. https://doi.org/10.1016/S0735-1097(01)01200-1
- Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 2011;109:923-40. https://doi.org/10.1161/CIRCRESAHA.111.243147
- Trachtenberg B, Velazquez DL, Williams AR, et al. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TACHFT) trial: a randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J 2011;161:487-93. https://doi.org/10.1016/j.ahj.2010.11.024
- Quevedo HC, Hatzistergos KE, Oskouei BN, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 2009;106:14022-7. https://doi.org/10.1073/pnas.0903201106
- Williams AR, Trachtenberg B, Velazquez DL, et al. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res 2011;108:792-6. https://doi.org/10.1161/CIRCRESAHA.111.242610
- Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008;28:208-16.
- McCall FC, Telukuntla KS, Karantalis V, et al. Myocardial infarction and intramyocardial injection models in swine. Nat Protoc 2012;7:1479-96. https://doi.org/10.1038/nprot.2012.075
- Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-302. https://doi.org/10.1161/01.CIR.0000070596.30552.8B
- Bubela T, Li MD, Hafez M, Bieber M, Atkins H. Is belief larger than fact: expectations, optimism and reality for translational stem cell research. BMC Med 2012;10:133. https://doi.org/10.1186/1741-7015-10-133
Cited by
- Recent Advances of Stem Cell Therapy for Retinitis Pigmentosa vol.15, pp.8, 2013, https://doi.org/10.3390/ijms150814456